E-LIB Suche - Ergebnisse für: Uhrenholt, Line

1

Exploring TNFi drug-levels and anti-drug antibodies during ..:

Uhrenholt, Line ; Sørensen, Mads E. R. ; Lauridsen, Karen B....
Rheumatology International. , 2024

2

Predicting successful biologics tapering in patients with i..:

Uhrenholt, Line ; Duch, Kirsten ; Christensen, Robin...
British Journal of Clinical Pharmacology. 89 (2023) 10 - p. 3152-3164 , 2023

Link: https://doi.org/10.1111/..

3

Isolation in patients with inflammatory rheumatic diseases ..:

Eriksen, Tobias Eschricht ; Dinesen, Wilfred K. H. ; Uhrenholt, Line...
Rheumatology International. 42 (2022) 5 - p. 783-790 , 2022

Link: https://doi.org/10.1007/..

4

Risk of flare after tapering or withdrawal of biologic/targ..:

Uhrenholt, Line ; Christensen, Robin ; Dinesen, Wilfred K H...
Rheumatology. 61 (2021) 8 - p. 3107-3122 , 2021

Link: https://doi.org/10.1093/..

5

Patient-reported outcome measures in systemic lupus erythem..:

Uhrenholt, Line ; Høstgaard, Simone ; Pedersen, Julie F...
Lupus. 30 (2021) 13 - p. 2124-2134 , 2021

Link: https://doi.org/10.1177/..

6

Incidence and severeness of COVID-19 hospitalization in pat..:

Cordtz, René ; Lindhardsen, Jesper ; Soussi, Bolette G...
Rheumatology. 60 (2020) SI - p. SI59-SI67 , 2020

Link: https://doi.org/10.1093/..

7

Active conventional treatment and three different biologica..:

Hetland, Merete Lund ; Haavardsholm, Espen A ; Rudin, Anna...
BMJ: British Medical Journal. 371 (2020) - p. 1-10 , 2020

Link: https://www.jstor.org/st..

8

Dosage reduction and discontinuation of biological disease-..:

Uhrenholt, Line ; Schlemmer, Annette ; Hauge, Ellen-Margrethe...
BMJ Open. 9 (2019) 7 - p. e028517 , 2019

Link: https://doi.org/10.1136/..

9

Predicting successful biologics tapering in patients with i..:

Uhrenholt, Line ; Duch, Kirsten ; Christensen, Robin...
https://vbn.aau.dk/da/publications/5e3c5760-a458-4f95-b98a-26030d87bc26. , 2023

Link: https://vbn.aau.dk/da/pu..

10

Predicting successful biologics tapering in patients with i..:

Uhrenholt, Line ; Duch, Kirsten ; Christensen, Robin...
Uhrenholt , L , Duch , K , Christensen , R , Dreyer , L , Hauge , E M , Schlemmer , A , Taylor , P C & Kristensen , S 2023 , ' Predicting successful biologics tapering in patients with inflammatory arthritis : Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial ' , British Journal of Clinical Pharmacology , vol. 89 , no. 10 , pp. 3152-3164 . https://doi.org/10.1111/bcp.15806. , 2023

Link: https://pure.au.dk/porta..

11

Dose Reduction of Biological Therapies in Patients with Inf..:

Uhrenholt, Line
Uhrenholt , L 2022 , ' Dose Reduction of Biological Therapies in Patients with Inflammatory Arthritis : Maintaining Stable Disease Activity on Reduced Dose ' . https://doi.org/10.54337/aau488128861. , 2022

Link: https://vbn.aau.dk/da/pu..

12

Isolation in patients with inflammatory rheumatic diseases ..:

Eriksen, Tobias Eschricht ; Dinesen, Wilfred K. H ; Uhrenholt, Line...
https://vbn.aau.dk/da/publications/e8f15a12-cc15-4793-83dd-10f7a8ef1f42. , 2022

Link: https://vbn.aau.dk/da/pu..

13

Risk of flare after tapering or withdrawal of biologic/targ..:

Uhrenholt, Line ; Christensen, Robin ; Dinesen, Wilfred K. H...
https://vbn.aau.dk/da/publications/5e65d5e0-1a0e-480d-b90b-3dca7c61bcf2. , 2022

Link: https://vbn.aau.dk/da/pu..

14

Active conventional treatment and three different biologica..:

Hetland, Merete Lund ; Haavardsholm, Espen A ; Rudin, Anna...
https://www.bmj.com/content/371/bmj.m4328.long. , 2021

Link: http://hdl.handle.net/23..

15

Active conventional treatment and three different biologica..:

Hetland, Merete Lund ; Haavardsholm, Espen A ; Rudin, Anna...
http://urn.nb.no/URN:NBN:no-86725. , 2021

Link: http://hdl.handle.net/10..